Detalhe da pesquisa
1.
Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function.
Immunity;
49(5): 958-970.e7, 2018 11 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30446386
2.
Evaluating Anti-CD32b F(ab) Conformation Using Molecular Dynamics and Small-Angle X-Ray Scattering.
Biophys J;
115(2): 289-299, 2018 07 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30021105
3.
Upregulation of FcγRIIb on monocytes is necessary to promote the superagonist activity of TGN1412.
Blood;
125(1): 102-10, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25395427
4.
Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ Receptors.
J Immunol;
195(11): 5503-16, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26512139
5.
Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity.
Blood;
123(5): 669-77, 2014 Jan 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24227819
6.
Sequence enrichment profiles enable target-agnostic antibody generation for a broad range of antigens.
Cell Rep Methods;
3(5): 100475, 2023 May 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37323567
7.
Human leukocyte immunoglobulin-like receptors in health and disease.
Front Immunol;
14: 1282874, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38022598
8.
Targeting FcγRIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma.
J Hematol Oncol;
15(1): 42, 2022 04 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35410313
9.
Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject 'cold' tumors.
J Immunother Cancer;
10(1)2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35058324
10.
FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms.
Cell Rep;
40(3): 111099, 2022 07 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35858562
11.
HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy.
J Exp Clin Cancer Res;
41(1): 131, 2022 Apr 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35392965
12.
Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing.
Nat Commun;
12(1): 1277, 2021 02 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33627649
13.
FcγRIIb Expression Is Decreased on Naive and Marginal Zone-Like B Cells From Females With Multiple Sclerosis.
Front Immunol;
11: 614492, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33505402
14.
LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation.
JCI Insight;
5(18)2020 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32870822
15.
Domain binding and isotype dictate the activity of anti-human OX40 antibodies.
J Immunother Cancer;
8(2)2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33428585
16.
Targeting the Antibody Checkpoints to Enhance Cancer Immunotherapy-Focus on FcγRIIB.
Front Immunol;
10: 481, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30930905
17.
Deep Mining of Complex Antibody Phage Pools Generated by Cell Panning Enables Discovery of Rare Antibodies Binding New Targets and Epitopes.
Front Pharmacol;
10: 847, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31417405
18.
Diet-Induced Abdominal Obesity, Metabolic Changes, and Atherosclerosis in Hypercholesterolemic Minipigs.
J Diabetes Res;
2018: 6823193, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29682581
19.
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.
Cancer Cell;
33(4): 649-663.e4, 2018 04 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29576375
20.
A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma.
PLoS One;
12(2): e0171205, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28158311